The popular weight-loss drug Wegovy reduced the risk of serious heart problems by 20% in a large, international study that experts say could change the way doctors treat certain heart patients.
The research is the first to document that an obesity medication can not only pare pounds, but also safely prevent a heart attack, stroke or a heart-related death in people who already have heart disease — but not diabetes.
The findings could shift perceptions that the new class of obesity drugs are cosmetic treatments and put pressure on health insurers to cover them.
Yeah I suppose you have a point. I guess I’m not trying to criticize that approach but trying to understand why the article says this drug will “shift perspectives.” Are they implying that instead of waiting until a patient develops symptoms of heart disease, they will prescribe meds to help control weight? Is that not what is already happening now?